Vaxcyte
- Market cap
- 9.96B
- P/E (TTM)i
- -8.78
- P/Bi
- 3.61
- EPSi
- -5.63
- Div yieldi
- 0.00%
- 52W posi
- 53%
Anonymous reader poll. Unscientific, not investment advice.
Vaxcyte last traded at 66.96, up 0.39% on the session. The company carries a market value of roughly 9.96B, the #1630 most valuable US-listed company we track. The 7 analysts covering the stock are, on balance, at Buy, targeting an average of 120.00 (+79%). Against a 52-week band of 39.87-90.75, the shares are currently 53% of the way up.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 13% of the universe, above its 200-day average.
- Signal has read BUY for 4 months.
- Its last 7 Buy calls have actually lost 15% on average three months out - the strategy's edge here has come from the basket, not from this ticker.
- Recent price momentum is +35.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 10.8% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 66.70
- Open
- 65.86
- Day range
- 64.27 - 67.15
- Avg price
- 66.00
- Volume
- 11.56M
- Turnover
- 763.14M
- Turnover ratei
- 8.48%
- Volume ratioi
- 1.92
- Amplitudei
- 4.32%
- 52-week rangei
- 39.87 - 90.75
Valuation
- P/Ei
- -11.89
- P/E (TTM)i
- -8.78
- P/Bi
- 3.61
- EPSi
- -5.63
- Book value / shi
- 18.53
- Net profit
- -837.77M
- Net assets
- 2.76B
Share structure
- Market cap
- 9.96B
- Float capi
- 9.14B
- Shares out
- 148.81M
- Float sharesi
- 136.44M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2020-06-12
26.2% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-51.13M net over the window
Short interest
- Shares short
- 16.13M
- % of floati
- 10.84%
- Days to coveri
- 13.04
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Vaxcyte (PCVX)?
Vaxcyte last traded at 66.96. The quote on this page refreshes every few seconds while US markets are open.
What is Vaxcyte's market cap?
About 9.96B.
What is the P/E ratio of Vaxcyte?
The trailing twelve-month P/E is -8.78. The Valuation tab shows it against the stock's own five-year range.
Does Vaxcyte pay a dividend?
Vaxcyte does not currently pay a regular dividend.
Is Vaxcyte a buy according to analysts?
The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 120.00, which implies 79.2% upside from the current price. This is not investment advice.
What is Vaxcyte's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Vaxcyte a B (Buy). Twelve-month momentum in the top 13% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 06:54:43 · For reference only, not investment advice and not tailored to your situation.